Chongqing Zhifei Biological Products Co Ltd
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
29 / 1361
Position in country
910 / 7387
Return on Assets, %
19.7
-40.3
Net income margin, %
17.4
-180
EBITDA margin, %
20.9
-168.2
Debt to Equity, %
14.4
3.2
Intangible assets and goodwill, %
2.4
0.2
Revenue CAGR 3Y, %
53.4
12.5
Total Equity change 1Y, %
16.8
-9
Revenue Y, % chg
23.7
0
P/E
11.6
31
P/BV
3.2
1.8
P/S
1.9
10.3
EV/S
2
7.5
EV/EBITDA
10
-1.6
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
60.2
131.1
Forward P/E
8.5
21.4
Dividend Yield, %
0.8
1.1
Forward Dividend Yield, %
0.3
0.1
Expected dividend per share
0.1
0
Payout Ratio, %
9.9
0
Dividend Ex Date
2023-06-16
Competitors
Ranks
-
Imeik Technology Development Co Ltd
00%
-
Chongqing Zhifei Biological Products Co Ltd
00%
-
Shanghai RAAS Blood Products Co Ltd
00%
-
Hualan Biological Engineering Inc
00%
-
Beijing Tiantan Biological Products Corp Ltd
00%
-
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
00%
-
Akeso Inc
00%
-
Gan & Lee Pharmaceuticals
00%
-
Innovent Biologics Inc
00%
-
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
China
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Sub-sector
Health Care
Capitalization (millions of $)
13576.3
Ticker
300122.SZ
ISIN
CNE100000V20
IPO date
2010-09-28
Availability on Russian exchanges
No
Reporting for
2023-08-28
Date fact. publication of reports
2023-06-30
Company Description
Chongqing Zhifei Biological Products Co., Ltd. is a China-based company principally engaged in the research, development, production, sale and distribution of vaccine products. The Company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevision and treatment of tuberculosis, viral vaccines for the prevention of rabies virus, influenza virus and other virus, general drugs and other biological products, among others. The Company is also involved in the agency sale of vaccines. The Company distributes its products in domestic market and to overseas markets, with Central China as its main market.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: